我们从1973年开始用斑蝥制剂治疗中、晚期原发性肝癌,7年多来共收洽130例,本文介绍其疗效、副作用,加以分析讨论,并报告2例治疗后生存4年以上的病例。临床资料一、性别、年龄、职业:139例中男123例,女16例;10～19岁5例,20～29岁8例,30～39岁26例,40～49岁48例,50～59岁44例,60岁以上8例,工人60例,农民45例,职员42例,学生1例,知青1例。 Since 1973, we have started to use the cantharidin preparations for the treatment of primary and advanced primary liver cancer. We have collected 130 cases in more than 7 years. This article describes its efficacy and side effects, analyzes and discusses them, and reports 2 cases that survived after treatment for more than 4 years. . Clinical data 1. Gender, age, occupation: 139 cases of 123 males and 16 females; 5 to 10 years old, 8 to 20 years old, 26 to 30 to 39 years old, 48 to 40 to 49 years old, 50 There were 44 cases of ~59 years old, 8 cases of 60 years old and above, 60 cases of workers, 45 cases of farmers, 42 cases of staff, 1 case of students, and 1 case of educated youth.